TY  - GEN
AU  - Chew,D P
AU  - Bhatt,D L
TI  - Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials
SN  - 1444-0903
PY  - 2003///0123
KW  - Abciximab
KW  - Acute Disease
KW  - Angina, Unstable
KW  - drug therapy
KW  - Angioplasty, Balloon, Coronary
KW  - Antibodies, Monoclonal
KW  - pharmacology
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Eptifibatide
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Myocardial Infarction
KW  - Peptides
KW  - Platelet Aggregation Inhibitors
KW  - administration & dosage
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Randomized Controlled Trials as Topic
KW  - Risk Assessment
KW  - Risk Factors
KW  - Syndrome
KW  - Time Factors
KW  - Tirofiban
KW  - Treatment Outcome
KW  - Tyrosine
KW  - analogs & derivatives
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1046/j.1445-5994.2002.00226.x
ER  -